Commercialization of Surplus Lab Reagents

May 23, 2012 - 11:00am

Please join CTTC and Kerafast, Inc. on Wednesday, May 23 at 11:00 a.m. in MRB III, room 1220, for a presentation regarding the commercialization of surplus laboratory reagents (e.g. antibodies, expression vectors, peptides, siRNA, small and large molecule compounds, etc.). Kerafast representatives will be on site to discuss The Investigator's Annexe, their innovative approach to reagent commercialization. 

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter